Unlocking Burn Healing: Aegle’s Breakthrough Therapy
Aegle Therapeutics Corp., a clinical-stage biotechnology company, has announced the initiation of its Phase 1/2a clinical trial, marking the dosing of its first patient. The trial will focus on the administration of AGLE-102™, a novel therapy designed to treat severe second-degree burns. AGLE-102™ is an investigational product made up of native extracellular vesicles, which are […]
2023’s Inventor: Dr. Laurencin’s Regenerative Breakthrough
The Intellectual Property Owners Education Foundation (IPOEF) has honored Dr. Cato T. Laurencin with the esteemed title of “Inventor of the Year” for 2023. This recognition is attributed to Dr. Laurencin’s revolutionary advancements in the field of regenerative engineering. His pioneering work has paved the way for clinical systems that facilitate the healing and regeneration […]
Caring Cross Unveils Affordable Genetic Therapy Strategies
New press release announces the role of Caring Cross, a non-profit organization, in a newly published white paper from the Innovative Genomics Institute, titled “Making Genetic Therapies Affordable and Accessible.” The white paper is the result of yearlong research and focuses on strategies to increase the affordability and accessibility of genetic therapies, including CAR-T technology […]
$32.3M Boost: City of Hope’s Groundbreaking Therapies
City of Hope, a prominent cancer research and treatment organization in the United States, has received a grant of $32.3 million from the California Institute for Regenerative Medicine (CIRM). Funding Allocation The funds will be used to support three novel Phase 1 clinical trials that focus on innovative cell and gene therapy treatments for patients […]
AvenCell’s AVC-201: A New Era in Leukemia Therapy
AvenCell Therapeutics, a leading clinical-stage cell therapy company, has announced that the European Medicines Agency (EMA) has approved its Clinical Trial Application (CTA) for AVC-201. AVC-201 is a novel allogeneic CD123-directed switchable CAR-T investigational therapy for the treatment of relapsed/refractory Acute Myeloid Leukemia (AML) and other CD123 positive hematological malignancies. This therapy is the world’s […]
Revolutionary Placental Biomaterials Transform Cell Therapy
Celularity Inc., a biotechnology company specializing in placental-derived allogeneic cell therapies and biomaterial products, has announced that it will present data on its proprietary extracellular matrices (ECM) at the International Conference on Biomaterials Science and Tissue Engineering (ICBSTE), taking place from July 24-26 in Osaka, Japan. The data includes benchtop and clinical case studies for […]
Unlocking Stem Cells: Revolution in Regenerative Medicine with Dr. Melihcan Sezgic
The video above is a presentation by Dr. Melih Can Sezgic at the Regenerative Medicine Symposium, where he discusses the role of stem cells in regenerative medicine, particularly in the fields of plastic, reconstructive, and aesthetic surgery. Here’s a detailed summary of the key points: Please note that this is a summary of a complex […]
NurOwn: Revolutionizing ALS Treatment with Biomarkers
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell therapeutics for neurodegenerative diseases, has presented new biomarker data from the Phase 3 trial of its late-stage investigational ALS treatment, NurOwn, at the 2023 ALS and Related Motor Neuron Diseases Gordon Research Conference. The data showed that treatment with NurOwn significantly elevated markers of […]
Stem Cells: Unleashing Hope for Unimaginable Healing
The video above is a comprehensive exploration of the potential of stem cells in treating various health conditions. The video highlights several groundbreaking stem cell trials and the transformative impact they have had on patients’ lives. Duchenne Muscular Dystrophy: The video begins with the story of Hunter Horkheimer, a young man diagnosed with Duchenne muscular […]
Weissman Lab & Fixstars: Revolutionizing Stem Cell Research
The Weissman Lab, led by Dr. Irving Weissman, a professor at Stanford University in Pathology and Developmental Biology, is set to collaborate with Fixstars Solutions starting in July 2023. The collaboration will focus on in-situ sequencing research, specifically targeting bone marrow blood vessel cells found within mice and the stromal cells from the skeletal stem […]